These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18094999)

  • 1. N-acetyl-L: -cysteine reduces the parasitism of BALB/c mice infected with Leishmania amazonensis.
    Monteiro MC; Marques FC; Blazius RD; Santos da Silva O; de Queiroz Cunha F; Bento DB; Torres Romão PR
    Parasitol Res; 2008 Mar; 102(4):801-3. PubMed ID: 18094999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological outcome of Leishmania major-infected BALB/c mice is improved by oral treatment with N-acetyl-l-cysteine.
    Rocha-Vieira E; Ferreira E; Vianna P; De Faria DR; Gaze ST; Dutra WO; Gollob KJ
    Immunology; 2003 Mar; 108(3):401-8. PubMed ID: 12603607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana.
    Aguilar Torrentera F; Lambot MA; Laman JD; Van Meurs M; Kiss R; Noël JC; Carlier Y
    Am J Trop Med Hyg; 2002 Mar; 66(3):273-9. PubMed ID: 12139220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hairless mice as an experimental model of infection with Leishmania (Leishmania) amazonensis.
    Araujo VC; Fukutani KF; Oshiro ET; Rodrigues PO; Rizk YS; Carollo CA; Arruda CC
    Exp Parasitol; 2015 Oct; 157():138-44. PubMed ID: 26234915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
    Courret N; Lang T; Milon G; Antoine JC
    Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
    Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
    J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice.
    Almeida RP; Barral-Netto M; De Jesus AM; De Freitas LA; Carvalho EM; Barral A
    Am J Trop Med Hyg; 1996 Feb; 54(2):178-84. PubMed ID: 8619444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.
    Felizardo TC; Gaspar-Elsas MI; Lima GM; Abrahamsohn IA
    Exp Parasitol; 2012 Jan; 130(1):48-57. PubMed ID: 22019418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyl-L-cysteine reduces Leishmania amazonensis-induced inflammation in BALB/c mice.
    Crupi R; Gugliandolo E; Siracusa R; Impellizzeri D; Cordaro M; Di Paola R; Britti D; Cuzzocrea S
    BMC Vet Res; 2020 Jan; 16(1):13. PubMed ID: 31931804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
    Al-Abdely HM; Graybill JR; Loebenberg D; Melby PC
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2910-4. PubMed ID: 10582881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Experimental Infection with L. ( L.) Amazonensis in X-Linked Immunodeficient Mice.
    Gonzaga WFKM; Geraldo MM; Vivanco BC; Popi AF; Mariano M; Batista WL; Xander P
    J Parasitol; 2017 Dec; 103(6):708-717. PubMed ID: 28783468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of glutathione modulators on the course of Leishmania major infection in susceptible and resistant mice.
    Cruz KK; Fonseca SG; Monteiro MC; Silva OS; Andrade VM; Cunha FQ; Romão PR
    Parasite Immunol; 2008 Mar; 30(3):171-4. PubMed ID: 18251971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of inflammation response to murine cutaneous Leishmaniasis by homeopathic medicines: Antimonium crudum 30cH.
    Rodrigues de Santana F; de Paula Coelho C; Cardoso TN; Perez Hurtado EC; Roberti Benites N; Dalastra Laurenti M; Villano Bonamin L
    Homeopathy; 2014 Oct; 103(4):264-74. PubMed ID: 25439043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis.
    Valadares DG; Duarte MC; Ramírez L; Chávez-Fumagalli MA; Lage PS; Martins VT; Costa LE; Ribeiro TG; Régis WC; Soto M; Fernandes AP; Tavares CA; Coelho EA
    Parasitol Res; 2012 Oct; 111(4):1807-16. PubMed ID: 22797606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc and Manganese Imbalances in BALB/c Mice Experimentally Infected with Leishmania (Leishmania) amazonensis.
    Sobotyk C; Baldissera FG; Rodrigues Junior LC; Romão PRT; de Oliveira JS; Dornelles GL; de Andrade CM; Maciel RM; Danesi CC; de Padua Ferreira RV; Bellini MH; de Avila Botton S; Vogel FSF; Sangioni LA
    Acta Parasitol; 2023 Jun; 68(2):447-452. PubMed ID: 36884141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing nystatin cream treatment efficacy against Leishmania (L.) amazonensis infection in BALB/c model.
    Gonçalves-Oliveira LF; Peixoto JF; Dias-Lopes G; Souza-Silva F; Côrtes LMC; Rocha HVA; Alves CR
    Exp Parasitol; 2023 Jul; 250():108547. PubMed ID: 37196701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice.
    Lemos de Souza V; Ascenção Souza J; Correia Silva TM; Sampaio Tavares Veras P; Rodrigues de-Freitas LA
    Microbes Infect; 2000 Dec; 2(15):1807-15. PubMed ID: 11165924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct courses of infection with Leishmania (L.) amazonensis are observed in BALB/c, BALB/c nude and C57BL/6 mice.
    Velasquez LG; Galuppo MK; DE Rezende E; Brandão WN; Peron JP; Uliana SR; Duarte MI; Stolf BS
    Parasitology; 2016 May; 143(6):692-703. PubMed ID: 26892342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania.
    Gomes IN; Calabrich AF; Tavares Rda S; Wietzerbin J; de Freitas LA; Veras PS
    Microbes Infect; 2003 Apr; 5(4):251-60. PubMed ID: 12706438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.